X0306
4
2018-01-02
0001588972
Recro Pharma, Inc.
REPH
0001398330
SCP Vitalife Partners II LP
SUITE 190
7 GREAT VALLEY PARKWAY
MALVERN,
PA
19355
0
0
1
0
Common Stock
2018-01-02
4
S
0
18947
9.037
D
2197495
D
Common Stock
2018-01-03
4
S
0
19863
8.733
D
2177632
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.7500 to $9.1800, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.60 to $8.95, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
/s/ Ryan Lake, Attorney-in-fact
2018-01-04